SeekingAlpha · Sep 3, 2026
Broadcom: Not Out Of The Woods, Just Cheaper (Rating Upgrade)
Broadcom Inc. stock is upgraded from sell to hold as AI ASIC margins fall but revenue accelerates. Click here to read this earnings update of AVGO.
OTC · ANTH
Anthera Pharmaceuticals, Inc.
Healthcare · Biotechnology
$0.00
Up+$0.00 (+0.00%)
Updated Oct 7, 2026, 5:02 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.62K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.00
- Volume
- 21K
- Avg. volume
- 5.56K
Price performance · ANTH
ANTH price history
1M range · 0 trading sessions · Daily adjusted prices
ANTH does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest ANTH news
The latest Smart Investors Daily articles mentioning ANTH.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ANTH research
Overview
Company profile and research snapshot.
Company profile
ANTHERA PHARMS INC NEW
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 21, 2018 | Roth Capital | Buy | — |
| Dec 29, 2016 | Citigroup | Neutral | — |
| Dec 29, 2016 | Jefferies | Hold | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
